"Intravenous Magnesium Sulfate as an adjunct in the treatment of severe Asthmatic patients non-responding to conventional therapy "

Treatment of acute asthma is based on rapid reversal of bronchospasm and arresting airway inflammation. This study was done to determine the effect of intravenous MgSO4 for improvement of pulmonary fuction in patients with acute asthma non-responding to routine therapy. This randomized, double –blin...

Full description

Bibliographic Details
Main Authors: Bijani KH, Moghadamnia AA, Islami Khalili E
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2001-12-01
Series:Acta Medica Iranica
Subjects:
Online Access:https://acta.tums.ac.ir/index.php/acta/article/view/2480
id doaj-c95236587ea249499fffd468c43e9c21
record_format Article
spelling doaj-c95236587ea249499fffd468c43e9c212020-11-25T03:21:42ZengTehran University of Medical SciencesActa Medica Iranica0044-60251735-96942001-12-01394"Intravenous Magnesium Sulfate as an adjunct in the treatment of severe Asthmatic patients non-responding to conventional therapy " Bijani KH0 Moghadamnia AA1 Islami Khalili E2 Treatment of acute asthma is based on rapid reversal of bronchospasm and arresting airway inflammation. This study was done to determine the effect of intravenous MgSO4 for improvement of pulmonary fuction in patients with acute asthma non-responding to routine therapy. This randomized, double –blind controlled study was conducted on 48 patients, magnesium sulfate group , n=48 aged 12-85 years, 26 men, 22 women, and control (saline) group, n=33, aged 15-80 years, 17 men, 16 women, who had not responded to routine treatment. Peak expiratory flow rate (PEFR) was done before MgSO4 (25 mg/kg) and normal saline (100 ml) as a baseline criteria and after infusion of drugs at 30 mm and 3 hr. All patients were also given bronchodilators. The main outcome was PEER. Data were analyzed by X2 and t-test and differences between each point, were considered significant at Phttps://acta.tums.ac.ir/index.php/acta/article/view/2480Acute asthmaNon-respondingMagnesium sulfate (MgSO4)Peak expiratory flow rate (PEER)
collection DOAJ
language English
format Article
sources DOAJ
author Bijani KH
Moghadamnia AA
Islami Khalili E
spellingShingle Bijani KH
Moghadamnia AA
Islami Khalili E
"Intravenous Magnesium Sulfate as an adjunct in the treatment of severe Asthmatic patients non-responding to conventional therapy "
Acta Medica Iranica
Acute asthma
Non-responding
Magnesium sulfate (MgSO4)
Peak expiratory flow rate (PEER)
author_facet Bijani KH
Moghadamnia AA
Islami Khalili E
author_sort Bijani KH
title "Intravenous Magnesium Sulfate as an adjunct in the treatment of severe Asthmatic patients non-responding to conventional therapy "
title_short "Intravenous Magnesium Sulfate as an adjunct in the treatment of severe Asthmatic patients non-responding to conventional therapy "
title_full "Intravenous Magnesium Sulfate as an adjunct in the treatment of severe Asthmatic patients non-responding to conventional therapy "
title_fullStr "Intravenous Magnesium Sulfate as an adjunct in the treatment of severe Asthmatic patients non-responding to conventional therapy "
title_full_unstemmed "Intravenous Magnesium Sulfate as an adjunct in the treatment of severe Asthmatic patients non-responding to conventional therapy "
title_sort "intravenous magnesium sulfate as an adjunct in the treatment of severe asthmatic patients non-responding to conventional therapy "
publisher Tehran University of Medical Sciences
series Acta Medica Iranica
issn 0044-6025
1735-9694
publishDate 2001-12-01
description Treatment of acute asthma is based on rapid reversal of bronchospasm and arresting airway inflammation. This study was done to determine the effect of intravenous MgSO4 for improvement of pulmonary fuction in patients with acute asthma non-responding to routine therapy. This randomized, double –blind controlled study was conducted on 48 patients, magnesium sulfate group , n=48 aged 12-85 years, 26 men, 22 women, and control (saline) group, n=33, aged 15-80 years, 17 men, 16 women, who had not responded to routine treatment. Peak expiratory flow rate (PEFR) was done before MgSO4 (25 mg/kg) and normal saline (100 ml) as a baseline criteria and after infusion of drugs at 30 mm and 3 hr. All patients were also given bronchodilators. The main outcome was PEER. Data were analyzed by X2 and t-test and differences between each point, were considered significant at P
topic Acute asthma
Non-responding
Magnesium sulfate (MgSO4)
Peak expiratory flow rate (PEER)
url https://acta.tums.ac.ir/index.php/acta/article/view/2480
work_keys_str_mv AT bijanikh intravenousmagnesiumsulfateasanadjunctinthetreatmentofsevereasthmaticpatientsnonrespondingtoconventionaltherapy
AT moghadamniaaa intravenousmagnesiumsulfateasanadjunctinthetreatmentofsevereasthmaticpatientsnonrespondingtoconventionaltherapy
AT islamikhalilie intravenousmagnesiumsulfateasanadjunctinthetreatmentofsevereasthmaticpatientsnonrespondingtoconventionaltherapy
_version_ 1724612997032181760